STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

FATE FATE THERAPEUTICS INCORPORATED StockScouter® Report

6

StockScouter® Score

FATE THERAPEUTICS INCORPORATED, a small cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • Moving average analysis for FATE suggests weak price movement over the medium term. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for FATE. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 60% done.
Low
High

Core Model Grades

B
C
A
F

Previous Ratings

6
5
3